FLAD1
protein-codingflavin adenine dinucleotide synthetase 1
Gene summary
This gene encodes the enzyme that catalyzes adenylation of flavin mononucleotide (FMN) to form flavin adenine dinucleotide (FAD) coenzyme. Alternatively spliced transcript variants encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~9.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009703
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0009703
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0009703
Submitter: ClinGen
FLAD1 was first reported in relation to autosomal recessive myopathy with abnormal lipid metabolism in 2014 (Taylor RW, et al., 2014; PMID: 25058219). Twelve variants (including missense, in-frame deletions, nonsense, splicing, and frameshift) have been reported in 13 probands, and three additional family members, in seven publications (PMIDs: 30061063, 30982706, 25058219, 30311138, 27259049, 31392824, 30427553). This gene-disease association is also supported by experimental evidence including its biochemical function in catalysis of FMN into FAD (PMID: 16643857), which is altered in patient cells (PMID: 27259049), as well as an expression pattern consistent with disease (PMID: 20060505), and a C. elegans model (PMID: 22306247). In summary, FLAD1 is definitively associated with autosomal recessive myopathy with abnormal lipid metabolism. This classification was approved by the ClinGen FAO GCEP 12/16/2020 (SOP Version [7]). This gene-disease pair was originally evaluated by the FAO GCEP on 06/12/2018. It was reevaluated on 12/15/2020. Additional genetic evidence was included from new publications (PMIDs: 30061063, 30982706, 30311138, 31392824, 30427553). As a result of this reevaluation, the classification was upgraded from moderate to definitive.
Inheritance Pattern: AR
Disease ID:MONDO:0009703
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009703
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Cardiovascular; Neurologic
Intervention: Biochemical; Cardiovascular
Rationale: Individuals have shown clinical improvement with dietary management (riboflavin); The condition has been described with cardiomyopathy, and awareness may allow prompt diagnosis and management (eg, with medical management and ICD)
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to FLAD1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_025207.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 94 | 1 | 96 | ||
| missense | 3 | 158 | 15 | 176 | ||
| nonsense | 4 | 4 | 1 | 9 | ||
| start loss | 0 | |||||
| frameshift | 12 | 5 | 1 | 18 | ||
| splice donor/acceptor (+/-2bp) | 4 | 2 | 6 | |||
| Total | 16 | 16 | 163 | 109 | 1 | 305 |
Highest pathogenic variant AF is 0.000057004912
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_079483.3 | 7 | MANE Select | |
| Ensembl | ENSP00000292180.3 | 7 | MANE Select | |
| RefSeq | NP_001171820.1 | 6 | Standard | |
| RefSeq | NP_001171821.1 | 1 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Riboflavin metabolism - Homo sapiens (human)
- Riboflavin Metabolism
- Selenium Micronutrient Network
- Folate Metabolism
- Metabolism
Biological Process
- FAD biosynthetic process
- riboflavin metabolic process
Molecular Function
- FMN adenylyltransferase activity
- protein binding
- ATP binding
Cellular Component
- mitochondrial matrix
- cytosol
- plasma membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000292180
- Coding exons
- 7
- Length
- 9774
- Individuals with no LoFs
- 125706
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 42
- Defined
- 125748
- p
- 0.000167
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.581 | 306 | 336 | 0.911 | 0.0000190 | 3728 |
| Missense (PolyPhen) | 92 | 103.66 | 0.88755 | 1144 | ||
| Synonymous | 1.72 | 111 | 137 | 0.812 | 0.00000702 | 1273 |
| Loss of Function | 3.07 | 8 | 24.4 | 0.328 | 0.00000131 | 271 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00018 | 0.00018 | rare |
| Latino/Admixed American | 0.00023 | 0.00023 | rare |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00019 | 0.00019 | rare |
| South Asian | 0.00016 | 0.00016 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Catalyzes the adenylation of flavin mononucleotide (FMN) to form flavin adenine dinucleotide (FAD) coenzyme. {ECO:0000269|PubMed:16643857, ECO:0000269|PubMed:27259049}.;
- Disease
- DISEASE: Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency (LSMFLAD) [MIM:255100]: An autosomal recessive, inborn error of metabolism characterized by variable mitochondrial dysfunction. Clinical features range from severe cardiac and respiratory insufficiency with onset in infancy and resulting in early death, to mild muscle weakness with onset in adulthood. Some patients show significant improvement with riboflavin treatment. Analysis of skeletal muscle show multiple mitochondrial respiratory chain deficiency and a lipid storage myopathy in most patients. {ECO:0000269|PubMed:27259049}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.232
Intolerance Scores
- LoFtool
- 0.0672
- RVIS EVS
- -1.04
- RVIS percentile EVS
- 7.71
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.999
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |